These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 21404136

  • 1. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
    Makino K, Hirai T, Nakamura H, Murakami R, Kitajima M, Shigematsu Y, Nakashima R, Shiraishi S, Uetani H, Iwashita K, Akter M, Yamashita Y, Kuratsu J.
    Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
    [Abstract] [Full Text] [Related]

  • 2. 18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI.
    Zhou W, Wen J, Hua F, Xu W, Lu X, Yin B, Geng D, Guan Y.
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [Abstract] [Full Text] [Related]

  • 3. [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
    Kawai N, Miyake K, Okada M, Yamamoto Y, Nishiyama Y, Tamiya T.
    No Shinkei Geka; 2013 Feb; 41(2):117-26. PubMed ID: 23378387
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
    Yamashita K, Hiwatashi A, Togao O, Kikuchi K, Kitamura Y, Mizoguchi M, Yoshimoto K, Kuga D, Suzuki SO, Baba S, Isoda T, Iwaki T, Iihara K, Honda H.
    J Magn Reson Imaging; 2016 Nov; 44(5):1256-1261. PubMed ID: 27093558
    [Abstract] [Full Text] [Related]

  • 5. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
    Choi YS, Lee HJ, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Lee SK.
    Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
    [Abstract] [Full Text] [Related]

  • 6. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J, Kumar Gupta P, Awasthi A, Pandey CM, Singh A, Patir R, Ahlawat S, Sadashiva N, Mahadevan A, Kumar Gupta R.
    Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [Abstract] [Full Text] [Related]

  • 7. Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining 18F-fluorodeoxyglucose Positron Emission Tomography with Arterial Spin Labeling.
    Hatakeyama J, Ono T, Takahashi M, Oda M, Shimizu H.
    Neurol Med Chir (Tokyo); 2021 Jun 15; 61(6):367-375. PubMed ID: 33967177
    [Abstract] [Full Text] [Related]

  • 8. Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma.
    Matsushima N, Maeda M, Umino M, Suzawa N, Yamada T, Takeda K.
    Ann Nucl Med; 2012 Apr 15; 26(3):262-71. PubMed ID: 22311413
    [Abstract] [Full Text] [Related]

  • 9. 18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma.
    Kong Z, Jiang C, Zhu R, Feng S, Wang Y, Li J, Chen W, Liu P, Zhao D, Ma W, Wang Y, Cheng X.
    Neuroimage Clin; 2019 Apr 15; 23():101912. PubMed ID: 31491820
    [Abstract] [Full Text] [Related]

  • 10. Distinguishing between primary central nervous system lymphoma and glioblastoma using [18F]fluoromisonidazole and [18F]FDG PET.
    Uchinomura S, Mitamura K, Norikane T, Yamamoto Y, Oishi A, Hatakeyama T, Miyake K, Nishiyama Y.
    Nucl Med Commun; 2022 Mar 01; 43(3):270-274. PubMed ID: 34864812
    [Abstract] [Full Text] [Related]

  • 11. Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    Ko CC, Tai MH, Li CF, Chen TY, Chen JH, Shu G, Kuo YT, Lee YC.
    PLoS One; 2016 Mar 01; 11(9):e0162565. PubMed ID: 27631626
    [Abstract] [Full Text] [Related]

  • 12. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.
    Invest Radiol; 2013 May 01; 48(5):247-55. PubMed ID: 23519008
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Primary central nervous system lymphoma and glioblastoma: differentiation using dynamic susceptibility-contrast perfusion-weighted imaging, diffusion-weighted imaging, and (18)F-fluorodeoxyglucose positron emission tomography.
    Nakajima S, Okada T, Yamamoto A, Kanagaki M, Fushimi Y, Okada T, Arakawa Y, Takagi Y, Miyamoto S, Togashi K.
    Clin Imaging; 2015 May 01; 39(3):390-5. PubMed ID: 25547624
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
    Lu S, Wang S, Gao Q, Zhou M, Li Y, Cao P, Hong X, Shi H.
    J Comput Assist Tomogr; 2017 May 01; 41(6):898-903. PubMed ID: 28806317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.